| 查看: 1658 | 回复: 7 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
如猫似狗金虫 (正式写手)
|
[交流]
一篇中药成分活性的综述英文手稿sci秒拒11回还有什么期刊可推荐试试？ 已有2人参与
|
||
|
大概1万字。拒稿11次，都没送审过，想再找一个sci期刊试试，如果还不行就打算试投普刊了。 1.ARCHIV DER PHARMAZIE，IF5.1，免费，年文章数164，rejected 2. PHYTOTHERAPY RESEARCH，IF7.2，免费，年文章数323，rejected 3.Fitoterapia，IF3.4，免费，年文章数214，收综述，rejected 4.Planta medica，拒稿 5.Phytomedicine，拒稿 6.Journal of TCM，拒稿 7.Frontier in pharmacology，拒稿，文中引文是作者年，文献列表是作者字母顺序 8.CNMJ, 拒稿，文中引文是数字，文献列表也是数字 9.Applied Sciences，拒稿，文中引文是数字，文献列表也是数字 10.Journal of Ethnopharmacology，拒稿 11.The American Journal of Chinese Medicine，拒稿 |
回复此楼» 猜你喜欢
NSFC申报书里申请人简历中代表性论著还需要在申报书最后的附件里面再上传一遍吗
已经有12人回复
-
伙伴们，祝我生日快乐吧
已经有21人回复
-
297一志愿上交085600求调剂
已经有5人回复
-
265求调剂
已经有4人回复
-
面上和青基一样限30页不合理
已经有7人回复
-
现在如何回避去年的某一个专家，不知道名字
已经有6人回复
-
304求调剂
已经有4人回复
-
283求调剂
已经有8人回复
-
255求调剂
已经有4人回复
-
080500，材料学硕302分求调剂学校
已经有4人回复
如猫似狗
金虫 (正式写手)
- 应助: 20 (小学生)
- 金币: 2312.9
- 散金: 170
- 红花: 3
- 帖子: 521
- 在线: 214.7小时
- 虫号: 1177656
- 注册: 2010-12-26
- 性别: GG
- 专业: 天然有机化学
5楼2024-11-27 16:19:06
2楼2024-11-22 20:26:01
3楼2024-11-25 13:49:38
如猫似狗
金虫 (正式写手)
- 应助: 20 (小学生)
- 金币: 2312.9
- 散金: 170
- 红花: 3
- 帖子: 521
- 在线: 214.7小时
- 虫号: 1177656
- 注册: 2010-12-26
- 性别: GG
- 专业: 天然有机化学
|
就Frontier in pharmacology给了些意见，我粘上来：The reason for this decision is: The content of this manuscript does not meet the standards of scientific quality or rigor required by the journal to be considered for peer review.质量和严谨性不过关 Thank you for this MS手稿, which certainly 当然，无疑is within our scope and potentially interesting. However, the review process has identified a series of further concerns. 综述过程有问题，有大问题There are major concerns and therefore, we cannot send your MS our to peer-review and we must reject your MS. The AE副编辑 highlighted: In its current form the MS in essence descriptive and a more critical analysis of the evidence. @@@现在手稿是描述性的，应该更加批判性的。What do the data you review show and what not 文献给出什么，没有给出什么(i.e. limitations, problems in the design of the studies and future research needs? @@@实验设计的局限性和问题是什么？将来研究方向？Please note: @@@If pharmacological studies are reviewed, we expect some information on the dose range tested剂量范围, the minimal active concentration最小有效浓度, the model used (incl. information whether it is an in vitro or in vivo study), if and what controls (incl positive and negative阳性对照和阴性对照) were used, duration, type of extract used as well as other basic pharmacological data. The same is in essence true for clinical studies. Often pharmacological activities are reported very naively天真和幼稚，有些paper烂, and such papers are especially common in journals with no or poor peer-review. This ranges from simple points like a use of appropriate controls and the full taxonomic validity分类学有效性 of the material under investigation (see also below), to the relevance of the model模型与所研究问题相关性 for the question being researched (e.g. can specific in silico or in vitro models really say s.th. about the species anti-inflammatory activity?例如计算机模拟或者体外模型能够说明物种的抗炎活性吗). Reviews must provide a specific and critical (!!) assessment of the literature. 综述必须对文献进行具体和批判性的（！！）评估。The scientific quality of the original articles must be critically assessed. 文献的质量必须严格评估。This includes the experimental design, and reliability of the studies研究的可靠性including a sufficiently detailed definition of the material under investigation. A description of the limitations and future research needs and priorities优先事项，当务之急 must be included.必须包括对局限性和未来研究需求和优先事项的描述。 |
4楼2024-11-27 16:10:40
